Kelly Traverso

Placeholder Person Graphic
Veeva Systems
Consultant
Kelly Traverso is responsible for the Vault Safety Suite strategy and associated consulting services for Veeva Systems, North America. She has over 18 years of life sciences industry and consulting experience, including extensive knowledge of US FDA and EMA safety and quality regulations. Applying specialized knowledge of regulatory and compliance, Kelly has developed and implemented strategies, designed and redesigned processes, supported technology implementations, and defi ned governance across the spectrum of pharmacovigilance activities for biotech and pharmaceutical companies.

Related Articles

The Untapped Potential of AI &  Automation in Pharmacovigilance
The Untapped Potential of AI &  Automation in Pharmacovigilance

Between 2009 and 2019, the number of adverse events (AEs) for drugs and therapeutic biologic products recorded by the US FDA Adverse Event Reporting System (FAERS) increased more than 300%, from 490,032 to 2.19 million cases (as of 31 December 2019).1

  • 1US Food and Drug Administration. “FDA Adverse Events Reporting System (FAERS) Public Dashboard: Data as of December 31, 2019.”...